If you're enrolled in Medicare or about to be, there's one decision that can quietly cost you thousands of dollars a year—choosing the wrong Medicare prescription drug plan. And unfortunately, it happens far more often than you'd think. According to a leading Medicare expert and author of Making the Most of Medicare , roughly 95% of Medicare beneficiaries are overspending on their prescriptions, largely because they pick a plan based on monthly premiums alone rather than evaluating the full picture of annual costs.

The truth is, not all Medicare Part D plans are created equal. Some have low star ratings from the Centers for Medicare and Medicaid Services (CMS), limited drug formularies, high out-of-pocket costs, and poor customer service records. And in 2026, the Part D landscape has shifted dramatically—with the total number of standalone prescription drug plans dropping from 464 in 2025 to just 360 nationwide. Major carriers have pulled out of markets or scaled back their offerings, leaving many beneficiaries scrambling to find new coverage.

In this guide, we'll walk through the worst Medicare Part D plans to avoid in 2026, the red flags that signal a bad plan, and exactly how to protect yourself from overpaying. Whether you live in North Bellmore , Long Island , or anywhere across New York, MediHealth Options is here to help you navigate this critical decision with clarity and confidence.

Why So Many Medicare Part D Plans Are Failing Beneficiaries in 2026

The 2026 Medicare Part D landscape looks significantly different from even a year ago. Financial pressures on insurance carriers—driven by the Inflation Reduction Act's (IRA) benefit redesign, rising healthcare costs, and reduced government reimbursement rates—have pushed several major insurers to scale back or exit the standalone prescription drug plan market entirely. UnitedHealthcare, Humana, and Aetna (CVS Health) have all made cuts to their Part D offerings, and Anthem has withdrawn its standalone PDPs from the market completely.

This consolidation means fewer choices for you. But fewer choices doesn't mean better choices. In fact, many of the plans still available carry low CMS star ratings, restrictive formularies, and cost structures that can leave you paying far more than you should. The average standalone Part D plan now has a summary rating of just 3 stars for 2026—and only about 1% of beneficiaries enrolled in standalone Part D plans are in a plan rated 4 stars or higher. Compare that to Medicare Advantage plans with prescription drug coverage, where roughly 64% of enrollees are in 4-star plans. The quality gap is staggering.

This is precisely why working with a knowledgeable Medicare broker matters more than ever. When plan availability shrinks and quality varies wildly, having someone who can analyze your specific medications against the full range of available plans isn't a luxury—it's a necessity. At MediHealth Options, our licensed advisors compare plans based on your actual prescriptions, your preferred pharmacies, and your total estimated annual costs—not just the premium number printed on a brochure.

Which Medicare Part D Plans Have the Worst Ratings in 2026?

Every year, CMS evaluates Medicare Part D plans on a 5-star scale, measuring everything from customer satisfaction and complaint history to how accurately plans estimate drug costs and how quickly they handle appeals. Plans rated below 3 stars are generally considered poor quality and may not adequately serve your healthcare needs. For 2026, several well-known names sit at the bottom of the ratings.

According to CMS data and independent analyses, the worst-rated Medicare Part D plans for 2026 include AARP/UnitedHealthcare and Blue Cross Blue Shield of IL, MT, OK, NM, and TX—both carrying a rating of just 2 out of 5 stars. Other poorly rated companies include Cigna (now operating under the HealthSpring brand for Part D) and several regional Blue Cross Blue Shield entities, including BlueRx and BCBS of Michigan. These plans may have some individual strengths, but their overall quality scores indicate they're not the best option for most people when it comes to prescription drug coverage.

It's important to understand that star ratings are assigned at the contract level, not the individual plan level. That means all plans under a given contract share the same rating. A carrier might offer a plan with an appealing premium, but if the contract behind it carries a 2-star rating, that low score reflects system-wide issues with customer service, formulary accuracy, or claims processing that will likely affect your experience. Before choosing any Part D plan, always check its star rating at Medicare.gov and compare it against alternatives available in your area.

7 Red Flags That Signal a Bad Medicare Part D Plan

Low star ratings are one thing, but the worst Medicare Part D plans share a number of other warning signs that aren't always obvious from a quick glance at a plan brochure. Here are the specific red flags to watch for when evaluating Medicare prescription plans for 2026.

1. Your medications aren't on the formulary. Every Part D plan maintains a formulary—a list of drugs the plan will cover. These formularies can vary dramatically from carrier to carrier. A medication that's Tier 2 (low cost) on one plan might be Tier 4 (high cost) on another, or not covered at all. Before enrolling, always cross-reference your specific medications against the plan's formulary. If even one of your regular prescriptions isn't listed, that plan could cost you hundreds or thousands of dollars out of pocket.

2. The plan has a high deductible. In 2026, no Part D plan can charge a deductible higher than $615. But some plans charge the full amount while others charge nothing at all. If you take multiple medications, a $615 deductible means you're paying full price for every prescription until you clear that threshold—which can be a painful hit to your budget in January and February.

3. Your preferred pharmacy isn't in the network. Part D plans contract with specific pharmacy networks, and many offer lower copays at "preferred" pharmacies. If your go-to pharmacy—whether it's a local shop in Bellmore or Merrick or a nationwide chain—isn't in the plan's preferred network, you could pay significantly more for the same medications. Plans can and do change their pharmacy networks annually, so even if your pharmacy was covered last year, verify it again for 2026.

4. The premium is suspiciously low. A $0 or near-$0 monthly premium might seem like a bargain, but it often comes with trade-offs: higher copays per prescription, a full $615 deductible, a more restrictive formulary, or higher tier placement for common drugs. The cheapest premium rarely equals the lowest total annual cost. At MediHealth Options, we calculate your estimated total annual spending—premiums plus deductible plus copays—to find the plan that actually costs you the least over a full year.

5. The plan has poor accuracy in drug pricing estimates. Some Part D plans have been flagged by CMS and independent reviewers for providing inaccurate drug cost estimates through the Medicare Plan Finder tool. This means the costs you see when shopping for a plan online may not match what you actually pay at the pharmacy. This is especially concerning in 2026, as the new $2,100 out-of-pocket cap hasn't been properly programmed into all plans' cost calculators. An expert with Making the Most of Medicare specifically warns that you might see projected costs of $12,000 or more when your actual maximum would be $2,100—so always double-check costs on the insurer's own website before enrolling.

6. The plan has a high complaint rate or members are leaving. CMS tracks complaint rates and the percentage of members choosing to leave a plan each year. If a plan has rising complaints and a declining membership base, that's a clear signal that real people are having real problems with their coverage. These metrics factor into star ratings, but they're also worth examining individually.

7. The plan was recently consolidated or restructured. With the market shrinking so dramatically in 2026, many plans have been merged, restructured, or shifted to new contracts. When this happens, your formulary, pharmacy network, and cost structure can all change—sometimes with very little notice. If your plan sent you an Annual Notice of Change (ANOC) announcing significant restructuring, treat that as a strong signal to shop around and compare alternatives.

The 2026 Part D Changes You Need to Understand

Before evaluating any Medicare Part D plan , it's essential to understand the major structural changes that took effect in 2026. The Inflation Reduction Act brought some of the most significant reforms to the Part D benefit since the program launched in 2006—and they directly affect which plans are worth your money.

The $2,100 out-of-pocket cap. For the first time ever, Medicare Part D beneficiaries now have a hard cap on their annual out-of-pocket prescription drug costs. Once you spend $2,100 in a calendar year on covered medications, your plan covers 100% of your drug costs for the rest of the year. The old "donut hole" or coverage gap has been completely eliminated. This is a game-changer for anyone taking expensive specialty medications or managing multiple chronic conditions. In 2022, the average Part D out-of-pocket cost was nearly $6,500—so this cap represents enormous savings for many seniors.

The $35 monthly insulin cap continues. If you use insulin, your cost remains capped at $35 per month regardless of the type or quantity of insulin you need. This protection, which first took effect in 2023, has saved approximately 1.5 million Medicare enrollees hundreds of dollars per year on diabetes management.

Negotiated prices for 10 high-cost drugs. For the first time in Medicare history, CMS has negotiated lower prices on 10 of the most expensive Part D drugs, including Eliquis (blood clots), Jardiance and Farxiga (diabetes), Xarelto (blood clots), Januvia (diabetes), Entresto (heart failure), Enbrel (rheumatoid arthritis), Imbruvica (cancer), Stelara (autoimmune conditions), and NovoLog/Fiasp (insulin). These negotiated prices represent discounts of 38% to 79% off list prices and are estimated to save beneficiaries $1.5 billion in 2026 alone. If you take any of these medications, make sure your plan covers them at the new negotiated rate.

These changes mean that even a "bad" plan won't bankrupt you the way it might have in prior years. But they don't eliminate the importance of choosing wisely. The difference between a good plan and a bad one can still easily be $1,000 to $2,000 per year in total costs—money that matters enormously when you're on a fixed income. The team at MediHealth Options can walk you through exactly how these new protections apply to your specific medications and help you find the plan that maximizes your savings.

How to Avoid the Worst Medicare Part D Plans: A Step-by-Step Approach

Knowing which plans to avoid is only half the battle. Here's a practical, step-by-step process for finding the right Medicare prescription drug plan for your needs in 2026—whether you're enrolling for the first time or switching from a plan that no longer works for you.

Step 1: Create a complete medication list. Write down every prescription you currently take, using the generic name (not just the brand name). Include the dosage and how often you take it. This is the foundation of any meaningful plan comparison. Medications are organized into tiers on each plan's formulary, and tier placement varies significantly between carriers—so the same drug might cost you $5 on one plan and $47 on another.

Step 2: Check star ratings first. Go to Medicare.gov and filter for Part D plans available in your ZIP code. Immediately eliminate any plan rated below 3 stars. Plans with 4 or 5 stars have demonstrated consistently higher quality in customer service, formulary accuracy, and complaint resolution. If there's a 5-star plan available in your area, you may even qualify for a Special Enrollment Period to switch outside of the normal open enrollment window.

Step 3: Compare total annual costs—not just premiums. Use the Medicare Plan Finder to estimate your total yearly costs including premiums, deductible, and copays for your specific drugs. Remember that the tool's estimates for 2026 may not perfectly reflect the new $2,100 out-of-pocket cap, so cross-reference estimates on each carrier's website. The lowest-premium plan is often not the cheapest plan overall.

Step 4: Verify your pharmacy network. Make sure your preferred pharmacy is in the plan's network—ideally in its "preferred" tier for the lowest copays. If you use mail-order pharmacy services, confirm those are covered too. For residents of Nassau County and Long Island , checking that your local pharmacy in Valley Stream , Rockville Centre , or Freeport is covered can save you a trip and real money.

Step 5: Work with a licensed Medicare advisor. This is where MediHealth Options makes the biggest difference. Our team does this analysis for you—running your medications through every available plan, factoring in pharmacy networks and total costs, and presenting you with clear, unbiased recommendations. There's no cost for our service and absolutely no pressure. We're here to make sure you don't end up in one of the worst Part D plans when a better option was available all along.

Why Your Plan from Last Year Might Be a Bad Plan This Year

One of the most common mistakes Medicare beneficiaries make is auto-renewing their Part D plan year after year without reviewing it. In a normal year, this can cost you money. In 2026, it can cost you a lot more—because the market has shifted so dramatically.

Plans change their formularies, pharmacy networks, premium amounts, copay structures, and tier placements every single year. A drug that was Tier 1 on your plan last year might have moved to Tier 3 this year. Your pharmacy might have been dropped from the preferred network. Your premium might have jumped $50 per month under the premium stabilization demonstration—the maximum increase CMS allows. The popular Wellcare Value Script plan, for example, saw premium increases in 33 states for 2026 while holding steady in only 16 and decreasing in just 2.

If your plan sent you an Annual Notice of Change (ANOC) in September, that document contains every modification coming to your plan in 2026. If you didn't read it—or didn't receive one because your plan was discontinued—you may already be enrolled in coverage that doesn't serve you well. This is why at MediHealth Options we offer annual plan reviews for every client. Each year during the Annual Enrollment Period (October 15 through December 7), we review your current medications, check for plan changes, and make sure you're still in the best possible prescription drug plan for your needs. It's a free service and it's something we believe every Medicare beneficiary deserves.

Should You Consider a Medicare Advantage Plan with Drug Coverage Instead?

With standalone Part D plans shrinking in number and declining in average quality, many beneficiaries are wondering whether a Medicare Advantage plan with built-in prescription drug coverage might be a better fit. It's a valid question—and the answer depends entirely on your individual situation.

Medicare Advantage plans (Part C) bundle your Part A, Part B, and usually Part D coverage into a single plan from a private insurer. Many offer $0 premiums for the drug coverage portion and include extras like dental, vision, hearing, and fitness benefits. For 2026, roughly 64% of Medicare Advantage enrollees with drug coverage are in plans rated 4 stars or higher—a dramatically better quality profile than standalone Part D plans. If you're considering this route, our advisors at MediHealth Options can help you compare Medicare Advantage enrollment options alongside standalone Part D plans to see which path truly gives you the best coverage for the lowest cost.

That said, Medicare Advantage isn't right for everyone. These plans typically use provider networks, which means you may be limited in which doctors and hospitals you can see. If you travel frequently, prefer the freedom to see any Medicare-accepting provider nationwide, or have complex health conditions that require specialists outside a given network, a Medicare Supplement (Medigap) plan paired with a standalone Part D plan may still be the stronger choice. The key is making an informed decision—not defaulting into whatever you happen to be enrolled in.

How MediHealth Options Helps You Avoid the Worst Medicare Part D Plans

At MediHealth Options, we've spent over 15 years in the insurance industry helping Medicare beneficiaries across Long Island and the greater New York area make smart, confident decisions about their healthcare coverage. When it comes to Part D, our approach is simple: we do the homework so you don't have to.

Here's what that looks like in practice. When you sit down with us—whether in person at our North Bellmore office, over the phone, or at your home—we start by building a complete picture of your medication needs. We take your full prescription list, including dosages and quantities, and run it through every available Part D plan in your area. We compare formulary coverage, tier placements, copay amounts, deductible structures, pharmacy networks, and star ratings. Then we present you with a clear, side-by-side comparison showing your estimated total annual cost for each plan—not just the premium, but the real number you'll spend over 12 months.

We don't represent just one carrier. We work with carriers like Wellcare , Humana , Aetna , Cigna/HealthSpring , UnitedHealthcare , and more—so our recommendations are based purely on what's best for you, not on any single company's interests. And our support doesn't end after enrollment. We provide ongoing assistance year-round, answer your questions whenever they come up, and conduct annual reviews every fall to make sure your plan still fits your needs as medications and formularies change.

If you're currently enrolled in a Part D plan you're unsure about—or if you've received a notice that your plan is being discontinued for 2026—don't wait. Book your free Medicare consultation today or call 631-236-3348 to speak directly with a licensed advisor. We'll review your current coverage, identify whether you're in one of the worst Medicare Part D plans, and help you switch to something better—at no cost to you. Because at MediHealth Options, it's simple: people first, people always.